Roche Holding AG (RHHVF) Receives a Hold from J.P. Morgan

By Jason Carr

In a report released today, Richard Vosser from J.P. Morgan maintained a Hold rating on Roche Holding AG (RHHVFResearch Report), with a price target of CHF360.00. The company’s shares closed last Friday at $369.00.

Vosser has an average return of 13.8% when recommending Roche Holding AG.

According to, Vosser is ranked #412 out of 7641 analysts.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Roche Holding AG with a $405.81 average price target, a 9.8% upside from current levels. In a report issued on September 7, UBS also maintained a Hold rating on the stock with a CHF350.00 price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $411.44 and a one-year low of $308.57. Currently, Roche Holding AG has an average volume of 4,952.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.